摘要: Objective. Strokes occur rarely in children, and the causes are different from those adults. Frequently, more than 1 cause is found. The consequences lifelong significant disability a majority of cases. Children who younger 18 years have not been included therapeutic trials thrombolytic or neuroprotective agents. We evaluated whether children receive diagnosis stroke meet major inclusion criterion for such trials, namely time to Methods. Prospective documentation retrospective chart review was conducted were 0 carried during last 2 hospital database, including presented with either ischemic hemorrhagic strokes. Results. Forty-seven events encountered 41 children. Twelve neonates stroke, diagnosed neonatal period, excluded subsequent analysis. In remaining 29 mean age at presentation 8.67 years. Accurate records available 24 this group, 28 recorded. Time clinical onset first medical contact averaged 28.5 hours, 35.7 hours. subsequently separated between (21 documented events) strokes (7 events), because intervention options different. Conclusions. Stroke frame 3 6 Given outcome group might benefit thrombolysis therapy, yet long delay excludes most cases being considered treatments. This situation should encourage attempts increase public professional awareness potential value early treatment, preferably by broadening current educational efforts all groups.